Dechra Pharmaceuticals PLC — Board/Management Information 2018

Dec 18, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8392K

Dechra Pharmaceuticals PLC

18 December 2018

18 December 2018

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company") 

Director's Declaration

In accordance with Listing Rule 9.6.14(2) Dechra announces that Tony Rice, Non-Executive Chairman of Dechra, is to be appointed as a Non-Executive Director of Ultra Electronics Holdings plc with effect from 18 December 2018 and its Chair from 28 January 2019.

For further information:

Melanie Hall, Company Secretary           

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNBBBDDUGBBGII